About AJNA BioSciences
AJNA BioSciences is a private company based in Littleton, Colorado, incorporated in 2021 in Delaware. It has reported $8,975,106 raised in two offerings on Form D since December 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2024 | Jun 10, 2024 | $2,105,106fully sold | 57 | $36,932 | Equity, DebtRule 506(b) | Form D ↗ |
| Sep 30, 2021 | Dec 21, 2021 | $6,870,000fully sold | 27 | $254K | Debt, Options, Securities on exercise, Each convertible promissory note bears interest of 6% and is convertible into Series A Common Stock of the issuer.Rule 506(b) | Form D ↗ |
| Total, two offerings | $8,975,106 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AJNA BioSciences's Form D filed Jun 10, 2024.
Earlier filings also listed Scott Humphreys (executive officer, last listed Dec 2021), Rose Marcario (director, last listed Dec 2021), John Held (director, last listed Dec 2021), Jared Stanley (director, last listed Dec 2021), Jacques Tortoroli (director, last listed Dec 2021), Gregory Gould (chief financial officer, last listed Dec 2021) and Antony Caracciolo (director, last listed Dec 2021).